Sponsors Visit the Colorado BioScience Association website Visit the Rocky Mountain Innovation Initiative Visit the Fitzsimons website Visit the Holland & Hart website Visit the Fitzsimons Redevelopment Authority website Visit the Holland & Hart website Visit the CU Business School website Visit the Colorado BioScience Association website Visit the Fitzsimons Redevelopment Authority website Visit the Holland & Hart website Visit the CU Business School website Visit the Colorado BioScience Association website
 
 
 

2011 Biobootcamp Presenter

Patty Telgener
Vice President of Reimbursement Services at Emerson Consultants, Inc

Patty Telgener is the Vice President of Reimbursement Services at Emerson Consultants, Inc. It is a company focused on offering Reimbursement, Regulatory, Clinical and Market Development consulting to the medical device, biologic and pharmaceutical industries. Currently, Patty is working with numerous medical device, diagnostic, and biologic companies ranging from start-ups to multi-billion dollar organizations.

Prior to joining Emerson Consultants, Patty was Director of Reimbursement for Medtronic Neurological and Medtronic Diabetes for over 14 years. She was also a healthcare consultant with Deloitte and Touche where she conducted hospital financial analyses and implemented new patient care delivery systems and has eight years of nursing experience in pediatric intensive care and emergency room.

Patty's reimbursement experience includes development and implementation of reimbursement strategies. She has experience successfully lobbying for new legislation to secure reimbursement of a new technology, working with professional societies to obtain CPT codes and working with CMS to obtain ICD-9-CM codes, HCPCS codes and payment for new technologies. Patty has also successfully obtained payments for new technologies and has worked directly with physicians, hospitals and payers to ensure appropriate coverage and payment.

Patty has been involved in research and due diligence activities for numerous new technologies. These market research activities included clinical research, competitive analysis (devices and pharmaceutical interventions) and economic analysis. Patty has also leveraged this research to help payer and provider customers understand the clinical and economic impact of new technologies. Patty has a strong understanding of what clinical and economic data is necessary to bring a product to market and secure positive coverage and payment determinations.

Patty is currently on the Advisory Board for Wolters Kluwer-Mediregs and is the Coding Consultant for American Association of Diabetes Educators (AADE).
Patty has an MBA from the American Graduate School (Thunderbird) and a Bachelor of Science in Nursing from Marquette University.